You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

Recruiting
  • Cancer
  • +11 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023

Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

Not yet recruiting
  • Unresectable Lung Non-Small Cell Carcinoma
  • serplulimab plus chemotherapy as conversion treatment
  • (no location specified)
Apr 27, 2023

DevelopingShared Decision Making Tool for Surgically Removed

Recruiting
  • Lung Non-Small Cell Carcinoma
  • Discussion
  • Questionnaire Administration
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)

Not yet recruiting
  • Resectable Lung Non-Small Cell Carcinoma
  • Biospecimen Collection
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Adenosine A2B Receptor Antagonist PBF-1129
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 1, 2023

Non Small Cell Lung Cancer, Non-small Cell Carcinoma Trial in Belgium (Physical activity tele coaching program)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Non-small Cell Carcinoma
  • Physical activity tele coaching program
  • Genk, Limburg, Belgium
  • +5 more
Sep 28, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Best Practice
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 14, 2023

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

Lung Non-Small Cell Carcinoma Trial in Buffalo (Pembrolizumab)

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • Pembrolizumab
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 27, 2023

Profiling of Pembrolizumab and Nivolumab in Melanoma and/or

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • Melanoma
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 13, 2023

Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
Oct 3, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +1 more
Aug 24, 2023

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +12 more
  • Computed Tomography
  • Contrast Agent
  • New Brunswick, New Jersey
  • +1 more
Nov 2, 2022

Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer

Active, not recruiting
  • Metastatic Lung Non-Small Cell Squamous Carcinoma
  • +7 more
  • Los Angeles, California
  • +9 more
Dec 17, 2022

Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Duarte, Rochester, Columbus (Best Practice, Biospecimen

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Best Practice
  • +5 more
  • Duarte, California
  • +2 more
Nov 14, 2023

Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Biopsy
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 2, 2022

Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Amivantamab
  • +3 more
  • (no location specified)
Oct 30, 2023

EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

Recruiting
  • EGFR Exon 20 Mutation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

NSCLC, Non-small Cell Carcinoma Trial (Automated Coaching Program (ACP), Manual Coaching Program (MCP))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Non-small Cell Carcinoma
  • Automated Coaching Program (ACP)
  • Manual Coaching Program (MCP)
  • (no location specified)
Oct 3, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023